Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi

Hillegass, J.M., Blumen, S.R., Cheng, K., MacPherson, M.B., Alexeeva, V., Lathrop, S.A.,
Beuschel, S.L., Steinbacher, J.L., Butnor, K.J., Ramos-Niño, M.E., Shukla, A., James, T.A.,
Weiss, D.J., Taatjes, D.J., Pass, H.I., Carbone, M., Landry, C.C., Mossman, B.T., 2011. Increased
efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. Int.
J. Cancer 129, 233-244.
Ho, H.-O., Su, H.-L., Tsai, T., Sheu, M.-T., 1996. The preparation and characterization of solid
dispersions on pellets using a fluidized-bed system. Int. J. Pharm. 139, 223-229.
Holm, P., Buur, A., Elema, M., Onne, Mollgaard, B., Holm, J., Egeskov, Schultz, K., 2007.
Controlled agglomeration, US Patent No. 7,217,431.
Horcajada, P., Rámila, A., Férey, G., Vallet-Regí, M., 2006. Influence of superficial organic
modification of MCM-41 matrices on drug delivery rate. Solid State Sci. 8, 1243-1249.
Horcajada, P., Rámila, A., Pérez-Pariente, J., Vallet-Reg, M., 2004. Influence of pore size of
MCM-41 matrices on drug delivery rate. Microporous and Mesoporous Materials 68, 105–109.
Hsiao, J.-K., Tsai, C.-P., Chung, T.-H., Hung, Y., Yao, M., Liu, H.-M., Mou, C.-Y., Yang, C.-S.,
Chen, Y.-C., Huang, D.-M., 2008. Mesoporous silica nanoparticles as a delivery system of
gadolinium for effective human stem cell tracking. Small 4, 1445-1452.
Huang, L.-F., Tong, W.-Q., 2004. Impact of solid state properties on developability assessment of
drug candidates. Adv. Drug Delivery Rev. 56, 321-334.
Huang, S., Fan, Y., Cheng, Z., Kong, D., Yang, P., Quan, Z., Zhang, C., Lin, J., 2009. Magnetic
mesoporous silica spheres for drug targeting and controlled release. J. Phys. Chem. C 113, 1775-
1784.
Huang, X., El-Sayed, I.H., Qian, W., El-Sayed, M.A., 2006. Cancer cell imaging and photothermal
therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120.
Huang, X., Teng, X., Chen, D., Tang, F., He, J., 2010. The effect of the shape of mesoporous silica
nanoparticles on cellular uptake and cell function. Biomaterials 31, 438-448.
Hubatsch, I., Ragnarsson, E.G.E., Artursson, P., 2007. Determination of drug permeability and
prediction of drug absorption in Caco-2 monolayers. Nat. Protocols 2, 2111-2119.
Hudson, S.P., Padera, R.F., Langer, R., Kohane, D.S., 2008. The biocompatibility of mesoporous
silicates. Biomaterials 29, 4045-4055.
Huh, S., Chen, H.-T., Wiench, J.W., Pruski, M., Lin, V.S.-Y., 2005. Cooperative catalysis by
general acid and base bifunctionalized mesoporous silica nanospheres. Angew. Chem. Int. Ed. 44,
1826-1830.
Hämäläinen, M.D., Frostell-Karlsson, A., 2004. Predicting the intestinal absorption potential of
hits and leads. Drug Discov. Today Technol. 1, 397-405.
Hörter, D., Dressman, J.B., 1997. Influence of physicochemical properties on dissolution of drugs
in the gastrointestinal tract. Adv. Drug Delivery Rev. 25, 3-14.
IARC, 1997. IARC working group on the evaluation of carcinogenic risks to humans. Silica, some
silicates, coal dust and para-aramid fibrils. World Health Organization, IARCPress, UK.
51